Breathing Easy: ALung CEO Talks Novel Hemolung Device, FDA's Breakthrough Pathway, Landmark US/UK Clinical Trials

 
• By Shawn M. Schmitt
  
Pete DeComo and Harold Safferstein in lab
ALung CEO Pete DeComo (left) points out a feature on the Hemolung device to Pittsburgh Life Sciences Greenhouse's Harold Safferstein on Oct. 16 at the company's Pittsburgh headquarters • Source: Shawn M. Schmitt

More from Respiratory

More from Device Area